NAVAMEDIC (NAVA.OL) Stock Earnings & Estimates
Europe - OSL:NAVA - NO0010205966 - Common Stock
21.4 NOK
-1.3 (-5.73%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 382.135M 37.26% | 511.997M 33.98% | 531.436M 3.80% | 597.72M 12.47% | 745.62M 24.74% | 844.56M 13.27% | 902.65M 6.88% | 968.48M 7.29% | 1.02B 5.32% | 1.053B 3.24% | 1.088B 3.32% | |
| EBITDA YoY % growth | 51.686M 183.68% | 51.567M -0.23% | 72.137M 39.89% | 54.06M -25.06% | 78.54M 45.28% | 103.02M 31.17% | 114.39M 11.04% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 44.444M 286.47% | 39.641M -10.81% | 31.795M -19.79% | 18.36M -42.26% | 59.16M 222.22% | 82.62M 39.66% | 99.74M 20.72% | 117.69M 18.00% | 133.65M 13.56% | 144.62M 8.21% | 153.6M 6.21% | |
| Operating Margin | 11.63% | 7.74% | 5.98% | 3.07% | 7.93% | 9.78% | 11.05% | 12.15% | 13.10% | 13.73% | 14.12% | |
| EPS YoY % growth | N/A 1,856.23% | N/A -43.13% | N/A 44.94% | -0.14 -111.04% | 1.36 1,050.00% | 2.17 60.15% | 3.86 77.47% | N/A | N/A | N/A | N/A |
All data in NOK
| Q3 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.61 -14.29% |
| Revenue Q2Q % growth | 145.86M 18.53% |
| EBITDA Q2Q % growth | 19.38M 31.03% |
| EBIT Q2Q % growth | 15.3M 221.16% |
All data in NOK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -45.69% | 0.61 | % | |
| Q1 2025 Q2Q % growth | -0.42 -364.67% | 0.50 | -0.92 | -184.31% |
| Q4 2024 Q2Q % growth | -0.70 -236.90% | 0.10 | -0.80 | -796.05% |
| Q3 2024 Q2Q % growth | 83.08% | 0.71 | % | |
| Q2 2024 Q2Q % growth | 1.13 226.62% | 0.91 | 0.21 | 23.47% |
| Q1 2024 Q2Q % growth | -0.09 -111.88% | 0.29 | -0.38 | -131.30% |
| Q4 2023 Q2Q % growth | -56.48% | 0.51 | % | |
| Q3 2023 Q2Q % growth | 0.39 1,174.51% | 0.32 | 0.07 | 23.34% |
| Q2 2023 Q2Q % growth | -0.89 | 0.20 | -1.09 | -547.46% |
| Q1 2023 Q2Q % growth | 0.77 | 0.43 | 0.33 | 76.70% |
| Q4 2022 Q2Q % growth | 1.17 | 0.48 | 0.69 | 141.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 137.277M -12.17% | 147.9M | -10.623M | -7.18% |
| Q1 2025 Q2Q % growth | 132.024M 9.23% | 139.38M | -7.356M | -5.28% |
| Q4 2024 Q2Q % growth | 131.196M 4.70% | 133.77M | -2.574M | -1.92% |
| Q3 2024 Q2Q % growth | 123.062M -12.72% | 149.94M | -26.878M | -17.93% |
| Q2 2024 Q2Q % growth | 156.305M 26.09% | 151.42M | 4.885M | 3.23% |
| Q1 2024 Q2Q % growth | 120.873M -0.75% | 133.11M | -12.237M | -9.19% |
| Q4 2023 Q2Q % growth | 125.311M 8.06% | 136.68M | -11.369M | -8.32% |
| Q3 2023 Q2Q % growth | 140.999M 51.92% | 119.85M | 21.149M | 17.65% |
| Q2 2023 Q2Q % growth | 123.967M 12.33% | 125.46M | -1.493M | -1.19% |
| Q1 2023 Q2Q % growth | 121.787M 93.32% | 110.67M | 11.117M | 10.05% |
| Q4 2022 Q2Q % growth | 115.967M 28.62% | 114.75M | 1.217M | 1.06% |
| Q3 2022 Q2Q % growth | 92.811M 45.88% | 93.84M | -1.029M | -1.10% |
| Q2 2022 Q2Q % growth | 110.361M 67.18% | % | ||
| Q1 2022 Q2Q % growth | 62.996M 7.42% | % | ||
| Q4 2021 Q2Q % growth | 90.16M 63.03% | % | ||
| Q3 2021 Q2Q % growth | 63.62M 12.01% | % | ||
| Q2 2021 Q2Q % growth | 66.014M 56.67% | % | ||
| Q1 2021 Q2Q % growth | 58.644M 5.40% | % | ||
| Q4 2020 Q2Q % growth | 55.302M 17.01% | % | ||
| Q3 2020 Q2Q % growth | 56.799M 16.29% | % | ||
| Q2 2020 Q2Q % growth | 42.135M -10.77% | % | ||
| Q1 2020 Q2Q % growth | 55.642M 22.40% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -119.31% |
| Revenue | 0% | 0% | 0% | 2.42% |